Approval · Notice of Compliance 11995 · 2011
ZENHALE: Notice of Compliance 11995
Issued January 11, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11995
- Date
- January 11, 2011
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Corticosteroid / Long-acting beta2-agonist
Products in this notice
Medicinal ingredients
- MOMETASONE FUROATE 50 MCG per DOSE
- FORMOTEROL FUMARATE DIHYDRATE 5 MCG per DOSE
- MOMETASONE FUROATE 100 MCG per DOSE
- MOMETASONE FUROATE 200 MCG per DOSE